# Dapoxetine

## Priligy 30mg (3 tablets/box)

##### 

| 藥品代碼   | OPRI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Treatment of premature ejaculation (PE) in men                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 用法用量   | 30 mg 1-3 hours prior to sexual activity. The recommended dose: 30mg/day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌       | Hypersensitivity. Significant pathological cardiac conditions eg heart failure (NYHA class II-IV)， conduction abnormalities (2nd- or 3rd-degree AV block or sick sinus syndrome) not treated w/ a permanent pacemaker， ischemic heart disease， valvular disease. Concomitant w/ MAOIs， thioridazine， selective serotonin re-uptake inhibitors (SSRIs)， serotonin-norepinephrine re-uptake inhibitors (SNRIs)， TCAs or other medicinal/herbal products w/ serotonergic effects (including recreational drugs)， CYP3A4 inhibitors. Moderate & severe hepatic impairment (Child-Pugh class B & C). Childn <18 yr. |
| 副作用     | Dizziness， headache， nausea， insomnia， anxiety， agitation， restlessness， decreased libido， abnormal dreams， somnolence， attention disturbance， tremor， paraesthesia， blurred vision， tinnitus， flushing， sinus congestion， yawning， GI disturbances， hyperhidrosis， erectile dysfunction， fatigue， irritability， increased BP                                                                                                                                                                                                                                                                   |
| 孕期建議   | Uknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 哺乳期建議 | Unknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

